Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Ressource"
topic_facet:"Tumor Necrosis Factor-alpha"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Tumor+Necrosis+Factor-alpha%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%221365-2036%22&type0%5B%5D=ISN&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Tumor+Necrosis+Factor-alpha%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%221365-2036%22&type0%5B%5D=ISN&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Tumor+Necrosis+Factor-alpha%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%221365-2036%22&type0%5B%5D=ISN&op0%5B%5D=OR
PubPharm (304)
1
Editorial : golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring-author's reply
enthalten in:
Alimentary pharmacology & therapeutics
| 2023
von
Fumery, M.
|
Roblin, X.
CommentOn: Aliment Pharmacol Ther. 2023 Jun;57(11):1290-1298. - PMID 36849714
Wird geladen...
2
Editorial : golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring
enthalten in:
Alimentary pharmacology & therapeutics
| 2023
von
Hanzel, J.
|
Drobne, D.
CommentOn: Aliment Pharmacol Ther. 2023 Jun;57(11):1290-1298. - PMID 36849714
Wird geladen...
3
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease : results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Chanchlani, N.
|
Lin, S.
|
Auth, M.
| +99
CommentIn: Aliment Pharmacol Ther. 2022 Oct;56(8):1294-1295. - PMID 36168263
Wird geladen...
4
Editorial : the immunogenicity to second anti-TNF therapy (IMSAT) therapeutic drug monitoring study-defining the risk of the in-class switch
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Wilson, A.
CommentOn: Aliment Pharmacol Ther. 2022 Oct;56(8):1250-1263. - PMID 36039036
Wird geladen...
5
Transmural healing evaluated by magnetic resonance enterography in paediatric patients with Crohn's disease receiving maintenance treatment with biologics
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Choi, S.
|
Kim, E.
|
Jeon, T.
| +5
Wird geladen...
6
Paternal use of medications for inflammatory bowel disease and the risk of hospital-diagnosed infections in the offspring : a nationwide cohort study
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Friedman, S.
|
Garvik, O.
|
Nielsen, J.
| +1
CommentIn: Aliment Pharmacol Ther. 2022 Sep;56(5):902. - PMID 35934849
Wird geladen...
7
Editorial : golimumab thresholds to achieve stringent medium- and long-term therapeutic outcomes in patients with ulcerative colitis
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Mantzaris, G.
|
Papamichael, K.
CommentOn: Aliment Pharmacol Ther. 2022 Aug;56(4):614-624. - PMID 35509152
Wird geladen...
8
Editorial : golimumab thresholds to achieve stringent medium- and long-term therapeutic outcomes in patients with ulcerative colitis-Author's reply
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Taxonera, C.
CommentOn: Aliment Pharmacol Ther. 2022 Aug;56(4):614-624. - PMID 35509152
Wird geladen...
9
Review article : latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Fehily, S.
|
Al-Ani, A.
|
Abdelmalak, J.
| +9
CommentIn: Aliment Pharmacol Ther. 2023 Feb;57(3):353-354. - PMID 36641788
Wird geladen...
10
Review article : paradoxical psoriasis as a consequence of tumour necrosis factor antagonists in patients with inflammatory bowel disease
enthalten in:
Alimentary pharmacology & therapeutics
| 2022
von
Townsend, C.
|
Lovegrove, F.
|
Khanna, R.
| +1
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Thema: Tumor Necrosis Factor-alpha
Medienart
304
Aufsätze
304
E-Artikel
E-Ressourcen
Zeitschriftentitel
304
Alimentary pharmacology & therapeutics
Thema
Tumor Necrosis Factor-alpha
189
Journal Article
119
Comment
109
B72HH48FLU
109
Infliximab
90
Research Support, Non-U.S. Gov't
84
Antibodies, Monoclonal
78
Antibodies, Monoclonal, Humanized
74
Adalimumab
74
FYS6T7F842
69
Letter
59
Anti-Inflammatory Agents
46
Editorial
44
Review
40
Immunosuppressive Agents
35
Gastrointestinal Agents
34
9RV78Q2002
34
vedolizumab
26
Systematic Review
25
Multicenter Study
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
76
2020-
216
2010-2019
12
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
304
Englisch
Haven't found what you're looking for?
Wird geladen...